“ID:2043 Response to a 2-Indolinones laboratory based regimen analogous in cancerous-infected cells”, Biomed. Res. Ther., vol. 4, no. S, pp. S74-S75, Sep. 2017, doi: 10.15419/bmrat.v4iS.280.